These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20519181)

  • 1. [Hepatocellular carcinoma--from macroscopy to molecular pathology].
    Schaff Z; Kovalszky I; Lotz G; Kiss A
    Orv Hetil; 2010 Jun; 151(24):982-9. PubMed ID: 20519181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients.
    Burnett NP; Dunki-Jacobs EM; Callender GG; Anderson RJ; Scoggins CR; McMasters KM; Martin RC
    Am Surg; 2013 Jul; 79(7):716-22. PubMed ID: 23816006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
    Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
    Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Precancerous stages of hepatocellular carcinoma].
    Tanikawa K
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2055-61. PubMed ID: 8607615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver precancerous lesions and hepatocellular carcinoma: the histology report.
    Roncalli M; Terracciano L; Di Tommaso L; David E; Colombo M; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S361-72. PubMed ID: 21459342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
    Yap SF; Peh SC
    Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
    Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
    Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue.
    Pannain VL; Morais JR; Damasceno-Ribeiro O; Avancini-Alves V
    Ann Hepatol; 2012; 11(4):495-9. PubMed ID: 22700631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
    Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
    Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cell carcinoma antigen in human liver carcinogenesis.
    Guido M; Roskams T; Pontisso P; Fassan M; Thung SN; Giacomelli L; Sergio A; Farinati F; Cillo U; Rugge M
    J Clin Pathol; 2008 Apr; 61(4):445-7. PubMed ID: 17893121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Jin GZ; Yu WL; Dong H; Zhou WP; Gu YJ; Yu H; Yu H; Lu XY; Xian ZH; Liu YK; Cong WM; Wu MC
    J Hepatol; 2013 Sep; 59(3):510-7. PubMed ID: 23665285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and differential diagnosis of hepatocellular carcinoma].
    Drebber U; Dienes HP
    Pathologe; 2006 Jul; 27(4):294-9. PubMed ID: 16767425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
    Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
    Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.